When the kidneys are damaged—after surgery, cardiac arrest, or as a side effect of certain medications—doctors often face one ...
1. Huang J. Disitamab vedotin plus tislelizumab as nephron-sparing therapy for high-risk upper tract urothelial carcinoma: The phase II DISTINCT-I trial. Presented at: ESMO 2025 Congress; October ...
New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...
New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...
Vertex Pharmaceuticals Incorporated today announced updated data for povetacicept (pove) in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) from the ongoing RUBY-3 trial at the ...
Third quarter performance driven by strong portfolio royalty revenue growth of 47%2025 full year revenue guidance increased to $225 million - ...
Researchers from Aarhus University have discovered a protein that can predict whether kidney cells will survive or die after acute injury. The finding could pave the way for new treatments and benefit ...
9/9/2024 Patrick Industries Inc. ICON Direct Inc Patrick Industries Inc. has acquired RecPro.com, a leading e-commerce business and aftermarket platform. 9/3/2024 Barbour Plastics Inc. the profile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback